{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:14:25Z","timestamp":1791288865068,"version":"4.3.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.drup.2004.04.002","type":"journal-article","created":{"date-parts":[[2004,6,22]],"date-time":"2004-06-22T18:25:12Z","timestamp":1087928712000},"page":"195-208","source":"Crossref","is-referenced-by-count":126,"title":["Chemically modified tetracyclines as inhibitors of matrix metalloproteinases"],"prefix":"10.1016","volume":"7","author":[{"given":"Milin R.","family":"Acharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Venitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Figg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Sparreboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2004.04.002_BIB1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-5793(97)00605-4","article-title":"Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines","volume":"410","author":"Amin","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drup.2004.04.002_BIB2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01833259","article-title":"Expression of the stomelysin gene in fibroblastic cells of invasive carcinoma of the breast and other human tissues: a review","volume":"24","author":"Basset","year":"1993","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.drup.2004.04.002_BIB3","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.284.5415.808","article-title":"Effects of angiogenesis inhibitors on multistage carcinogenesis in mice","volume":"284","author":"Bergers","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.drup.2004.04.002_BIB4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S8756-3282(00)00297-0","article-title":"Tetracyclines induce apoptosis in osteoclasts","volume":"27","author":"Bettany","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.drup.2004.04.002_BIB5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/08959374980120010901","article-title":"Tetracycline derivatives induce apoptosis selectively in cultured monocytes and macrophages but not in mesenchymal cells","volume":"12","author":"Bettany","year":"1998","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.1999.tb07677.x","article-title":"Tissue inhibitors of matrix metalloproteinases in cancer","volume":"878","author":"Blavier","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.drup.2004.04.002_BIB7","first-page":"2556","article-title":"Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis","volume":"56","author":"Boolbol","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1368-7646(03)00026-8","article-title":"Resistance to cytotoxic and anti-angiogenic agents: similarities and differences","volume":"6","author":"Broxterman","year":"2003","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.drup.2004.04.002_BIB9","unstructured":"Cancer Trials, 2001. National Cancer Institute (http:\/\/www.cancer.gov\/clinical.htm)."},{"key":"10.1016\/j.drup.2004.04.002_BIB10","first-page":"353","article-title":"Assays of matrix metalloproteinases (MMPs) and MMP inhibitors: bioassays and immunoassays applicable to cell culture medium, serum, and synovial fluid","volume":"225","author":"Catterall","year":"2003","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.drup.2004.04.002_BIB11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/89.17.1260","article-title":"Changing views of the role of matrix metalloproteinases in metastasis","volume":"89","author":"Chambers","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2004.04.002_BIB12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/0929867013373615","article-title":"Biodistribution of radiolabeled [(3)H] CMT-3 in rats","volume":"8","author":"Chen","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drup.2004.04.002_BIB13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1200\/JCO.20.1.153","article-title":"Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi\u2019s sarcoma: a phase I AIDS malignancy consortium study","volume":"20","author":"Cianfrocca","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2004.04.002_BIB14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/08959374980120010701","article-title":"Modulation of nitric oxide production by tetracyclines and chemically modified tetracyclines","volume":"12","author":"Cillari","year":"1998","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB15","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"MMP inhibitors and cancer: trials and tribulations","volume":"295","author":"Coussens","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.drup.2004.04.002_BIB16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C","article-title":"Matrix metalloproteinases in tumor invasion and metastasis","volume":"189","author":"Curran","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.drup.2004.04.002_BIB17","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S1567-5769(01)00100-X","article-title":"Anti-inflammatory effects of chemically modified tetracyclines by the inhibition of nitric oxide and interleukin-12 synthesis in J774 cell line","volume":"1","author":"D\u2019Agostino","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.drup.2004.04.002_BIB18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1567-5769(02)00213-8","article-title":"Chemically modified tetracyclines induce cytotoxic effects against J774 tumour cell line by activating the apoptotic pathway","volume":"3","author":"D\u2019Agostino","year":"2003","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.drup.2004.04.002_BIB19","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/1097-0142(19940201)73:3<518::AID-CNCR2820730305>3.0.CO;2-T","article-title":"Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. An immunohistochemical study of 87 patients","volume":"73","author":"David","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.drup.2004.04.002_BIB20","first-page":"312","article-title":"Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells","volume":"17","author":"Duivenvoorden","year":"1997","journal-title":"Invasion Metast."},{"key":"10.1016\/j.drup.2004.04.002_BIB21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2004.04.002_BIB22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1749-6632.1999.tb07763.x","article-title":"Tetracycline derivative CMT-3 inhibits cytokine production, degranulation, and proliferation in cultured mouse and human mast cells","volume":"878","author":"Eklund","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.drup.2004.04.002_BIB23","first-page":"407","article-title":"Effects of doxycycline on in vitro growth, migration, and gelatinase activity of breast carcinoma cells","volume":"125","author":"Fife","year":"1995","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.drup.2004.04.002_BIB24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3835(98)00003-2","article-title":"Effects of doxycycline on human prostate cancer cells in vitro","volume":"127","author":"Fife","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2004.04.002_BIB25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0022-2143(97)90130-X","article-title":"Induction of apoptosis by doxycycline in cultured human osteosarcoma cells","volume":"130","author":"Fife","year":"1997","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.drup.2004.04.002_BIB26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3835(00)00348-7","article-title":"Effects of tetracyclines on angiogenesis in vitro","volume":"153","author":"Fife","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.drup.2004.04.002_BIB27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1699-0463.1999.tb01532.x","article-title":"Matrilysin in early stage intestinal tumorigenesis","volume":"107","author":"Fingleton","year":"1999","journal-title":"APMIS"},{"key":"10.1016\/j.drup.2004.04.002_BIB28","first-page":"1364","article-title":"TIMP-1 and adverse prognosis in non-small cell lung cancer","volume":"2","author":"Fong","year":"1996","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB29","first-page":"151","article-title":"Comparison of doxycycline and a chemically modified tetracycline inhibition of leukocyte functions","volume":"78","author":"Gabler","year":"1992","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.drup.2004.04.002_BIB30","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/jnci\/91.15.1281","article-title":"Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?","volume":"91","author":"Gelmon","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2004.04.002_BIB31","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF00686191","article-title":"The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism","volume":"36","author":"Gilbertson-Beadling","year":"1995","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.drup.2004.04.002_BIB32","first-page":"24","article-title":"Reduction with tetracyclines of excessive collagen degradation in periodontal and other diseases","volume":"56","author":"Golub","year":"1990","journal-title":"N.Y. State Dent. J."},{"key":"10.1016\/j.drup.2004.04.002_BIB33","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1600-0765.1984.tb01334.x","article-title":"Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease","volume":"19","author":"Golub","year":"1984","journal-title":"J. Periodont. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1902\/jop.1985.56.11s.93","article-title":"Tetracyclines inhibit tissue collagenases. Effects of ingested low-dose and local delivery systems","volume":"56","author":"Golub","year":"1985","journal-title":"J. Periodontol."},{"key":"10.1016\/j.drup.2004.04.002_BIB35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0765.1985.tb00405.x","article-title":"Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources","volume":"20","author":"Golub","year":"1985","journal-title":"J. Periodont. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB36","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/00220345870660080401","article-title":"A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity","volume":"66","author":"Golub","year":"1987","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/10454411910020030201","article-title":"Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs","volume":"2","author":"Golub","year":"1991","journal-title":"Crit. Rev. Oral. Biol. Med."},{"key":"10.1016\/j.drup.2004.04.002_BIB38","first-page":"315","article-title":"Tetracyclines (TCs) inhibit matrix metalloproteinases (MMPs): in vivo effects in arthritic and diabetic rats and new in vitro studies","volume":"1","author":"Golub","year":"1992","journal-title":"Matrix"},{"key":"10.1016\/j.drup.2004.04.002_BIB39","first-page":"80","article-title":"Host modulation with tetracyclines and their chemically modified analogues","volume":"2","author":"Golub","year":"1992","journal-title":"Curr. Opin. Dent."},{"key":"10.1016\/j.drup.2004.04.002_BIB40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/08959374980120010501","article-title":"Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms","volume":"12","author":"Golub","year":"1998","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB41","unstructured":"Greenwald, R.A., Hillen, W., Nelson, M., 2001. Tetracyclines in Biology, Chemistry and Medicine. Basel, Boston, p. 336."},{"key":"10.1016\/j.drup.2004.04.002_BIB42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/0929867013373642","article-title":"Inhibition of tumor cell invasiveness by chemically modified tetracyclines","volume":"8","author":"Gu","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drup.2004.04.002_BIB43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/AAC.37.2.191","article-title":"Expression of the tetK gene from Staphylococcus aureus in Escherischia coli: comparison of substrate specifities of TetA(B), TetA(C), and TetK efflux proteins","volume":"37","author":"Guay","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2004.04.002_BIB44","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/S0968-0896(02)00421-2","article-title":"2D-QSAR in hydroxamic acid derivatives as peptide deformylase inhibitors and antibacterial agents","volume":"10","author":"Gupta","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drup.2004.04.002_BIB45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/08959374980120010301","article-title":"Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells","volume":"12","author":"Hanemaaijer","year":"1998","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB46","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2165\/00003495-200059050-00002","article-title":"Clinical potential of matrix metalloprotease inhibitors in cancer therapy","volume":"59","author":"Heath","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.drup.2004.04.002_BIB47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1749-6632.2003.tb03218.x","article-title":"Remodeling of the microenvironment by aggressive melanoma tumor cells","volume":"995","author":"Hendrix","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.drup.2004.04.002_BIB48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1699-0463.1999.tb01533.x","article-title":"Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation","volume":"107","author":"Henriet","year":"1999","journal-title":"APMIS"},{"key":"10.1016\/j.drup.2004.04.002_BIB49","first-page":"4757","article-title":"Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry","volume":"63","author":"Hess","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB50","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ijc.2910490507","article-title":"Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours","volume":"49","author":"Hewitt","year":"1991","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2004.04.002_BIB51","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jnci\/93.3.178","article-title":"Development of matrix metalloproteinase inhibitors in cancer therapy","volume":"93","author":"Hidalgo","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2004.04.002_BIB52","first-page":"2891","article-title":"Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion","volume":"56","author":"Imren","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s000180050495","article-title":"Matrix metalloproteinases in tumor invasion","volume":"57","author":"Johansson","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.drup.2004.04.002_BIB54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-0625.1997.tb00164.x","article-title":"Matrix metalloproteinases in skin","volume":"6","author":"Kahari","year":"1997","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.drup.2004.04.002_BIB55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/07853899909019260","article-title":"Matrix metalloproteinases and their inhibitors in tumor growth and invasion","volume":"31","author":"Kahari","year":"1999","journal-title":"Ann. Med."},{"key":"10.1016\/j.drup.2004.04.002_BIB56","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1164\/ajrccm.156.6.9612046","article-title":"Association of expression of metalloproteinases and their inhibitors with the metastatic potential of squamous lung carcinomas","volume":"156","author":"Karameris","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.drup.2004.04.002_BIB57","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1749-6632.1994.tb24777.x","article-title":"Tissue healing with doxycycline and chemically modified tetracycline treatments in rats with Porphyromonas gingivalis-induced periodontitis","volume":"732","author":"Karimbux","year":"1994","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.drup.2004.04.002_BIB58","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1749-6632.1999.tb07757.x","article-title":"Non-antimicrobial and antimicrobial tetracyclines inhibit IL-6 expression in murine osteoblasts","volume":"878","author":"Kirkwood","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.drup.2004.04.002_BIB59","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1007\/s002800051097","article-title":"Matrix metalloproteinases and metastasis","volume":"43","author":"Kleiner","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.drup.2004.04.002_BIB60","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1749-6632.1994.tb24776.x","article-title":"The in vivo effect of doxycycline treatment on matrix metalloproteinases in reactive arthritis","volume":"732","author":"Lauhio","year":"1994","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.drup.2004.04.002_BIB61","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(95)91484-6","article-title":"Tetracyclines in treatment of rheumatoid arthritis","volume":"346","author":"Lauhio","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2004.04.002_BIB62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/0929867013373660","article-title":"CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer","volume":"8","author":"Lee","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drup.2004.04.002_BIB63","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1023\/A:1020901328583","article-title":"Evidence for dissolution rate-limited absorption in COL-3, a MMPI, leading to the irregular absorption profile in rats after oral administration","volume":"19","author":"Li","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB64","first-page":"99","article-title":"Metalloproteinases and cancer invasion","volume":"1","author":"Liotta","year":"1990","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2004.04.002_BIB65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/284067a0","article-title":"Metastatic potential correlates with enzymatic degradation of basement membrane collagen","volume":"284","author":"Liotta","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.drup.2004.04.002_BIB66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/0929867013373525","article-title":"The lipophilicity, pharmacokinetics, and cellular uptake of different chemically-modified tetracyclines (CMTs)","volume":"8","author":"Liu","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drup.2004.04.002_BIB67","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1902\/jop.2001.72.8.1069","article-title":"A combination of a chemically modified doxycycline and a bisphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats","volume":"72","author":"Llavaneras","year":"2001","journal-title":"J. Periodontol."},{"key":"10.1016\/j.drup.2004.04.002_BIB68","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1749-6632.1999.tb07690.x","article-title":"MMP inhibition in prostate cancer","volume":"878","author":"Lokeshwar","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.drup.2004.04.002_BIB69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/08959374980120012901","article-title":"Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer","volume":"12","author":"Lokeshwar","year":"1998","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB70","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/0929867013373516","article-title":"Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3)","volume":"8","author":"Lokeshwar","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drup.2004.04.002_BIB71","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.10168","article-title":"Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model","volume":"98","author":"Lokeshwar","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2004.04.002_BIB72","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm858","article-title":"Protease degradomics, a new challenge for proteomics","volume":"3","author":"Lopez-Otin","year":"2002","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.drup.2004.04.002_BIB73","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/(SICI)1097-0215(20000515)86:4<577::AID-IJC21>3.0.CO;2-J","article-title":"Down-regulation of trypsinogen-2 expression by chemically modified tetracyclines: association with reduced cancer cell migration","volume":"86","author":"Lukkonen","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2004.04.002_BIB74","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/08959374980120010801","article-title":"The effects of chemically modified tetracyclines (CMTs) on human keratinocyte proliferation and migration","volume":"12","author":"Makela","year":"1998","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB75","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1128\/AAC.46.3.755-761.2002","article-title":"Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells","volume":"46","author":"Mealey","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drup.2004.04.002_BIB76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1006732424102","article-title":"Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells","volume":"18","author":"Meng","year":"2000","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.drup.2004.04.002_BIB77","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1517\/13543784.10.6.1075","article-title":"Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug","volume":"10","author":"Mitsiades","year":"2001","journal-title":"Exp. Opin. Investig. Drugs"},{"key":"10.1016\/j.drup.2004.04.002_BIB78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1368-7646(03)00059-1","article-title":"Drug resistance and the microenvironment: nature and nurture","volume":"6","author":"Morin","year":"2003","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.drup.2004.04.002_BIB79","unstructured":"Munoz-Mateu, M., de\u2019Grafenried, L., Eckhardt, S., Malik, S., Rizzo, J., Kuhn, J., Rowinsky, E., Hidalgo, M., 2001. Pharmacodynamic studies of Col-3, a novel matrix metalloproteinase inhibitor in patients with advanced cancer. Proc. Am. Soc. Clin. Oncol. 20 302 (abstract)."},{"key":"10.1016\/j.drup.2004.04.002_BIB80","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/08959374980120012701","article-title":"Tetracycline-based MMP inhibitors can prevent fibroblast-mediated collagen gel contraction in vitro","volume":"12","author":"Myers","year":"1998","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB81","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"270","author":"Nagase","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2004.04.002_BIB82","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1200\/JCO.2000.18.5.1135","article-title":"Matrix metalloproteinases: biologic activity and clinical implications","volume":"18","author":"Nelson","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2004.04.002_BIB83","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrc884","article-title":"Strategies for MMP inhibition in cancer: innovations for the post-trial era","volume":"2","author":"Overall","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2004.04.002_BIB84","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.4049\/jimmunol.163.6.3459","article-title":"A novel mechanism of action of chemically modified tetracyclines: inhibition of COX-2-mediated prostaglandin E2 production","volume":"163","author":"Patel","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.drup.2004.04.002_BIB85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0378-5173(98)00417-7","article-title":"Degradation kinetics of 4-dedimethylamino sancycline, a new anti-tumor agent, in aqueous solutions","volume":"181","author":"Pinsuwan","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drup.2004.04.002_BIB86","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1021\/js980398l","article-title":"Spectrophotometric determination of acidity constants of 4-dedimethylamino sancycline (Col-3), a new antitumor drug","volume":"88","author":"Pinsuwan","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drup.2004.04.002_BIB87","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/0929867013373552","article-title":"Wound healing in ovariectomized rats: effects of chemically modified tetracycline (CMT-8) and estrogen on matrix metalloproteinases-8, -13 and type I collagen expression","volume":"8","author":"Pirila","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drup.2004.04.002_BIB88","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1524-475X.2002.10605.x","article-title":"Chemically modified tetracycline (CMT-8) and estrogen promote wound healing in ovariectomized rats: effects on matrix metalloproteinase-2, membrane type 1 matrix metalloproteinase, and laminin-5 gamma2-chain","volume":"10","author":"Pirila","year":"2002","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.drup.2004.04.002_BIB89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1054\/drup.2001.0210","article-title":"The role of Fas and FasL as mediators of anticancer chemotherapy","volume":"4","author":"Poulaki","year":"2001","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.drup.2004.04.002_BIB90","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/bjc.1997.285","article-title":"TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma","volume":"75","author":"Powe","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2004.04.002_BIB91","first-page":"1807","article-title":"Chemically modified non-antimicrobial tetracyclines inhibit activity of phospholipases A2","volume":"25","author":"Pruzanski","year":"1998","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.drup.2004.04.002_BIB92","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0889-8588(02)00044-8","article-title":"Development of matrix metalloproteinase inhibitors in cancer therapy","volume":"16","author":"Purcell","year":"2002","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.drup.2004.04.002_BIB93","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.LAB.0000038555.67772.DB","article-title":"Gelatin zymography and substrate cleavage assays of matrix metalloproteinase-2 in breast carcinoma cells overexpressing membrane type-1 matrix metalloproteinase","volume":"82","author":"Ratnikov","year":"2002","journal-title":"Lab. Invest."},{"key":"10.1016\/j.drup.2004.04.002_BIB94","first-page":"105","article-title":"Non-antimicrobial properties of tetracyclines\u2014dental and medical implications","volume":"50","author":"Rawal","year":"2001","journal-title":"West Indian Med. J."},{"key":"10.1016\/j.drup.2004.04.002_BIB95","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1183\/09031936.94.07112062","article-title":"The role of matrix metalloproteinases and their inhibitors in tumor invasion, metastasis and angiogenesis","volume":"7","author":"Ray","year":"1994","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.drup.2004.04.002_BIB96","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1749-6632.1994.tb24733.x","article-title":"Modulation of bone resorption by tetracyclines","volume":"732","author":"Rifkin","year":"1994","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.drup.2004.04.002_BIB97","first-page":"700","article-title":"Protracted daily treatment of COL-3, an oral tetracycline analog, MMP inhibitor is feasible a phase I, pharmacokinetic, and biological study","volume":"19","author":"Rowinsky","year":"2000","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.drup.2004.04.002_BIB98","first-page":"292a","article-title":"A phase I and pharmacokinetic PK study of COL-3 an oral tetracycline analog and selective MMP inhibitor","volume":"6","author":"Rowinsky","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB99","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0731-7085(00)00257-0","article-title":"High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasma","volume":"22","author":"Rudek","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.drup.2004.04.002_BIB100","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.2001.19.2.584","article-title":"Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer","volume":"19","author":"Rudek","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2004.04.002_BIB101","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1592\/phco.22.9.705.34062","article-title":"Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy?","volume":"22","author":"Rudek","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drup.2004.04.002_BIB102","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/08959374980120011201","article-title":"Tetracyclines inhibit protein glycation in experimental diabetes","volume":"12","author":"Ryan","year":"1998","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB103","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00001813-200311000-00001","article-title":"Doxycycline and other tetracyclines in the treatment of bone metastasis","volume":"14","author":"Saikali","year":"2003","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.drup.2004.04.002_BIB104","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrc702","article-title":"The promise and peril of surrogate end-points in cancer research","volume":"2","author":"Schatzkin","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2004.04.002_BIB105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/08959374980120010101","article-title":"Application of chemically modified tetracyclines (CMTs) in experimental models of cancer and arthritis","volume":"12","author":"Seftor","year":"1998","journal-title":"Adv. Dent. Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB106","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1006588708131","article-title":"Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis","volume":"16","author":"Seftor","year":"1998","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.drup.2004.04.002_BIB107","first-page":"6322","article-title":"Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix\/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma","volume":"61","author":"Seftor","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2004.04.002_BIB108","first-page":"1173","article-title":"Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry","volume":"1","author":"Seftor","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2004.04.002_BIB109","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1749-6632.1999.tb07760.x","article-title":"CMT-3, a chemically modified tetracycline, inhibits bony metastases and delays the development of paraplegia in a rat model of prostate cancer","volume":"878","author":"Selzer","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.drup.2004.04.002_BIB110","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/1529-0131(199906)42:6<1140::AID-ANR10>3.0.CO;2-7","article-title":"Specificity of inhibition of matrix metalloproteinase activity by doxycycline","volume":"42","author":"Smith","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.drup.2004.04.002_BIB111","first-page":"1966","article-title":"Collagenase inhibition by tetracyclines","volume":"107","author":"Sorsa","year":"1991","journal-title":"Duodecim"},{"key":"10.1016\/j.drup.2004.04.002_BIB112","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/scbi.1996.0020","article-title":"MMP and tumor invasion: from correlation and casualty to the clinic","volume":"7","author":"Stetler-Stevenson","year":"1996","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.drup.2004.04.002_BIB113","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1083\/jcb.118.5.1271","article-title":"Coordinated expression of extracellular matrix degrading proteinases and their inhibitors regulates mammary epithelial function during involution","volume":"118","author":"Talhouk","year":"1992","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.drup.2004.04.002_BIB114","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00133561","article-title":"Correlation between spontaneous metastatic potential and type I collagenolytic activity in a human pancreatic cell line (SUIT-2) and sublines","volume":"10","author":"Taniguchi","year":"1992","journal-title":"Clin. Exp. Metast."},{"key":"10.1016\/j.drup.2004.04.002_BIB115","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.2108497","article-title":"Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo","volume":"247","author":"Teicher","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.drup.2004.04.002_BIB116","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.bjp.0704068","article-title":"Effects of chemically modified tetracyclines (CMTs) in sensitive, multidrug resistant and apoptosis resistant leukaemia cell lines","volume":"133","author":"Tolomeo","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drup.2004.04.002_BIB117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/bbrc.1996.1787","article-title":"Chemically modified tetracyclines inhibit inducible nitric oxide synthase expression and nitric oxide production in cultured rat mesangial cells","volume":"229","author":"Trachtman","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2004.04.002_BIB118","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1073\/pnas.94.7.3336","article-title":"Cyclooxygenase-2 expression in human colon cancer cells increase metastatic potential","volume":"94","author":"Tsuiji","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drup.2004.04.002_BIB119","unstructured":"Vernillo, A.T., Ramamurthy, N.S., Golub, L.M., Rifkin, B.R., 1994. The nonantimicrobial properties of tetracycline for the treatment of periodontal disease. Curr. Opin. Periodontol., 111\u2013118."},{"key":"10.1016\/j.drup.2004.04.002_BIB120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc701","article-title":"Scaling down imaging: molecular mapping of cancer in mice","volume":"2","author":"Weissleder","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2004.04.002_BIB121","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1368-7646(02)00120-6","article-title":"Activation of the PI3K\/Akt pathway and chemotherapeutic resistance","volume":"5","author":"West","year":"2002","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.drup.2004.04.002_BIB122","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1073\/pnas.94.4.1402","article-title":"Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drup.2004.04.002_BIB123","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/1523-1747.ep12359590","article-title":"Wound fluid from chronic leg ulcers contains elevated levels of MMP-2 and MMP-9","volume":"101","author":"Wysocki","year":"1993","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.drup.2004.04.002_BIB124","first-page":"131","article-title":"Enhanced RNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human breast cancer","volume":"69","author":"Yoshiji","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drup.2004.04.002_BIB125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0885-4505(92)90003-H","article-title":"HPLC determination of a chemically modified nonantimicrobial tetracycline: biological implications","volume":"47","author":"Yu","year":"1992","journal-title":"Biochem. Med. Metab. Biol."},{"key":"10.1016\/j.drup.2004.04.002_BIB126","first-page":"899","article-title":"Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph nodes and distinct metastasis","volume":"1","author":"Zeng","year":"1995","journal-title":"Clin. Cancer Res."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136876460400041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136876460400041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T22:05:14Z","timestamp":1682719514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S136876460400041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":126,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S136876460400041X"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2004.04.002","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}